Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

211
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
211
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

485
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
485
Local Anesthetics: Adverse Effects01:12

Local Anesthetics: Adverse Effects

504
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
504
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

248
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
248
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

267
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
267
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

2.3K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Women's Conferences in Medicine: Advancing Gender Equity in Medical Education.

The clinical teacher·2026
Same author

Photodistributed RIME Syndrome Treated With Etanercept.

Pediatric dermatology·2026
Same author

Healing from the Inside Out: Vitamins and Nutritional Strategies for Complex Regional Pain Syndrome and Chronic Postsurgical Pain.

Current pain and headache reports·2026
Same author

The OPRM1 A118G Polymorphism Revisited: Recent Developments and Implications for Personalized Treatment.

Current pain and headache reports·2026
Same author

Trends in Peripheral Nerve Block Use for Breast Contouring Surgery.

A&A practice·2026
Same author

Topical estrogens for skin aging: Use in hair loss and additional safety concerns for consideration.

Journal of the American Academy of Dermatology·2026

Related Experiment Video

Updated: Sep 19, 2025

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
07:52

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Published on: June 2, 2015

12.1K

Adverse Effects Associated With High-Dose Ketamine Infusions For Refractory Pain And Psychiatric Conditions.

Elika D Javaheri1, Christopher Wie2, Stephen Covington2

  • 1Mayo Clinic Alix School of Medicine, Phoenix, AZ, USA. javaheri.elika@mayo.edu.

Current Pain and Headache Reports
|June 19, 2025
PubMed
Summary

High-dose ketamine (HDK) use is linked to psychiatric issues like agitation and anxiety, alongside physical effects such as nausea and transient liver damage. Careful monitoring in clinical settings is advised, as adverse events are often dose-dependent.

Keywords:
Adverse EffectsComplex Regional Pain SyndromeEmergence ReactionsHepatotoxicityKetamineTreatment Resistant Depression

More Related Videos

Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury
07:07

Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury

Published on: February 10, 2020

10.7K
Intracranial Pharmacotherapy and Pain Assays in Rodents
02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

5.4K

Related Experiment Videos

Last Updated: Sep 19, 2025

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
07:52

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Published on: June 2, 2015

12.1K
Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury
07:07

Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury

Published on: February 10, 2020

10.7K
Intracranial Pharmacotherapy and Pain Assays in Rodents
02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

5.4K

Area of Science:

  • Anesthesiology
  • Pharmacology
  • Toxicology

Background:

  • Higher doses of ketamine are increasingly utilized for various medical conditions, including Complex Regional Pain Syndrome (CRPS).
  • Understanding the adverse effects (AEs) specifically associated with high-dose ketamine (HDK) is crucial for safe clinical practice.

Purpose of the Study:

  • To review and examine the common adverse effects explicitly associated with high doses of ketamine (HDK).

Main Methods:

  • Literature review of studies investigating adverse effects of high-dose ketamine.
  • Analysis of reported psychiatric and physical adverse events across different administration routes (oral, intravenous, intranasal).

Main Results:

  • HDK is frequently associated with psychiatric AEs, including agitation, anxiety, and sleep disturbances.
  • Emesis (nausea and vomiting) is a common AE, with increased prevalence at higher ketamine doses.
  • Hepatotoxicity and ketamine-induced uropathy are potential AEs, with hepatotoxicity being dose-dependent and typically transient.

Conclusions:

  • While HDK appears safe when administered and monitored appropriately in a hospital setting, clinicians must be aware of potential dose-dependent adverse effects.
  • Psychiatric symptoms, emesis, hepatotoxicity, and uropathy are key adverse events to consider with HDK therapy.